Strategies to Control Rising Health Insurance Premiums in Singapore

By João L. Carapinha

October 12, 2024

The article titled “Here’s what we can do to keep the lid on rising health insurance premiums” by Hwee-Lin Wee, published on October 9, 2024, discusses several strategies to manage and reduce the increasing health insurance premiums. The focus on rising health insurance premiums is critical as it impacts both individuals and broader healthcare systems. Here are the key points:

Changing Incentives for Doctors

The article suggests that insurers need to alter the way doctors are rewarded. Currently, the fee-for-service model can lead to overutilization of medical services, driving up costs. Changing this model to one that incentivizes preventive care and efficient treatment could help reduce unnecessary medical expenditures, ultimately keeping health insurance premiums lower.

Patient Education

Patients need to be educated on the appropriate use of healthcare services. This includes understanding when hospital visits are necessary and when alternative, less costly options are available. Educated patients can make more informed decisions, reducing unnecessary claims and thereby helping to keep health insurance premiums more manageable.

Preventive Health

The article emphasizes the importance of preventive health measures. Encouraging regular check-ups, healthy lifestyles, and early intervention can significantly reduce the need for costly medical treatments later on. Preventive health programs are highlighted as cost-effective and beneficial in the long run, contributing to a decrease in overall health insurance premiums.

Healthcare Financing

There is a discussion on the need for a balanced approach to healthcare financing. This includes ensuring that the financial burden is distributed fairly among different stakeholders, such as individuals, employers, and the government. Effective healthcare financing models can help stabilize health insurance premiums by spreading the risk and cost more evenly.

Systemic Changes

The article may also touch on broader systemic changes, like reinstating deductibles and expanding public health insurance coverage (e.g., MediShield Life) to include more affordable ward options. These changes can help break the “vicious circle” of rising health insurance premiums and claims.

Overall, the article advocates for a multi-faceted approach involving changes in doctor incentives, patient education, preventive health measures, and healthcare financing to control the rise in health insurance premiums. Focusing on these strategies will be essential to keep the lid on rising health insurance premiums and ensure more sustainable healthcare in the future.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.